These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 5723186)

  • 41. Interaction among d-amphetamine, scopolamine and genotype in avoidance behavior of rats.
    Satinder KP
    Pharmacol Biochem Behav; 1981 Jan; 14(1):121-4. PubMed ID: 7465605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction between cholinergic and catecholaminergic agents in a spontaneous alternation task.
    Kokkinidis L; Anisman H
    Psychopharmacology (Berl); 1976 Aug; 48(3):261-70. PubMed ID: 823581
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cholinergic influence on memory facilitation induced by angiotensin II in rats.
    Yonkov DI; Georgiev VP
    Neuropeptides; 1990 Jul; 16(3):157-62. PubMed ID: 1964494
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alteration of the behavioral effects of amphetamine by agents which modify cholinergic function.
    Goldberg ME; Ciofalo VB
    Psychopharmacologia; 1969; 14(2):142-9. PubMed ID: 5350623
    [No Abstract]   [Full Text] [Related]  

  • 45. Role of cholinergic mechanisms in states of wakefulness and sleep.
    Domino EF; Yamamoto K; Dren AT
    Prog Brain Res; 1968; 28():113-33. PubMed ID: 5749010
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of central and peripheral adrenergic and cholinergic modification on time-dependent processes in avoidance performance.
    Anisman H; Kokkinidis L
    Behav Biol; 1974 Feb; 10(2):161-71. PubMed ID: 4856064
    [No Abstract]   [Full Text] [Related]  

  • 47. The effect of D-amphetamine and physostigmine upon acquisition and retrieval in a single trial learning task.
    Bohdanecky Z; Jarvik ME
    Arch Int Pharmacodyn Ther; 1967 Nov; 170(1):58-65. PubMed ID: 6056593
    [No Abstract]   [Full Text] [Related]  

  • 48. Deficits in passive-avoidance learning following atropine in the developing rat.
    Blozovski D; Cudennec A; Garrigou D
    Psychopharmacology (Berl); 1977 Oct; 54(2):139-43. PubMed ID: 412208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lesions of cholinergic forebrain nuclei: changes in avoidance behavior and scopolamine actions.
    Lo Conte G; Bartolini L; Casamenti F; Marconcini-Pepeu I; Pepeu G
    Pharmacol Biochem Behav; 1982 Nov; 17(5):933-7. PubMed ID: 6294688
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of scopolamine and atropine on the performance of an exercise-avoidance test by dogs.
    Mennear JH; Samuel GK; Joffe MH; Kodama JK
    Psychopharmacologia; 1966; 9(4):347-50. PubMed ID: 5996940
    [No Abstract]   [Full Text] [Related]  

  • 51. Cholinergic modulation of an opposed effect of d-amphetamine and methylphenidate on the rearing response.
    Bryan KS; Ellison G
    Psychopharmacologia; 1975 Aug; 43(2):169-73. PubMed ID: 1187951
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cholinergic drug effects on antidepressant-induced behaviour in the forced swimming test.
    Mancinelli A; Borsini F; d'Aranno V; Lecci A; Meli A
    Eur J Pharmacol; 1988 Dec; 158(3):199-205. PubMed ID: 3253098
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ECS dissociation of learning and one-way cross-dissociation with physostigmine and scopolamine.
    Gardner EL; Glick SD; Jarvik ME
    Physiol Behav; 1972 Jan; 8(1):11-5. PubMed ID: 4677196
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of physostigmine, atropine and scopolamine on behavior maintained by a multiple schedule of food presentation in the mouse.
    Wenger GR
    J Pharmacol Exp Ther; 1979 Apr; 209(1):137-43. PubMed ID: 430373
    [No Abstract]   [Full Text] [Related]  

  • 55. Role of stimulus locale on strain differences in active avoidance after scopolamine of D-amphetamine treatment.
    Anisman H
    Pharmacol Biochem Behav; 1976 Jan; 4(1):103-6. PubMed ID: 1265090
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of scopolamine, atropine, and d-amphetamine on internal and external control of responding on non-reinforced trials.
    Heise GA; Lilie NL
    Psychopharmacologia; 1970 Aug; 18(1):38-49. PubMed ID: 5523375
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of cholinergic drugs on aversive operant behavior induced by dorsal central gray stimulation in rats.
    Moriyama M; Ichimaru Y; Gomita Y; Fukuda T
    Jpn J Pharmacol; 1985 Nov; 39(3):339-47. PubMed ID: 4094182
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amphetamine effects on poor performance of rats in a shuttle-box.
    Rech RH
    Psychopharmacologia; 1966; 9(2):110-7. PubMed ID: 5983910
    [No Abstract]   [Full Text] [Related]  

  • 59. Central and peripheral muscarinic actions of physostigmine and oxotremorine on avoidance responding of squirrel monkeys.
    Witkin JM
    Psychopharmacology (Berl); 1989; 97(3):376-82. PubMed ID: 2497488
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of posttraining injection of cholinergic agonists and antagonists into the amygdala on retention of passive avoidance training in rats.
    Todd JW; Kesner RP
    J Comp Physiol Psychol; 1978 Oct; 92(5):958-68. PubMed ID: 730861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.